2010
Addressing Research Priorities for Prevention of HIV Infection in the United States
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, Sadr W. Addressing Research Priorities for Prevention of HIV Infection in the United States. Clinical Infectious Diseases 2010, 50: s149-s155. PMID: 20397942, PMCID: PMC2862583, DOI: 10.1086/651485.Peer-Reviewed Original ResearchConceptsHIV infectionHuman immunodeficiency virusHispanic womenHIV Prevention Trials NetworkNew HIV infectionsClinical Trials GroupName-based reportingHigh rateImmunodeficiency virusAIDS diagnosisTrial groupUS womenInfected personsPrevention estimatesUS populationHealth messagesEthnic minority populationsTrials NetworkDisease controlInfectionWhite womenWomenPreventionNational InstituteMen
2006
Factors Associated with Delayed Initiation of HIV Medical Care Among Infected Persons Attending a Southern HIV/AIDS Clinic
Krawczyk CS, Funkhouser E, Kilby JM, Kaslow RA, Bey AK, Vermund SH. Factors Associated with Delayed Initiation of HIV Medical Care Among Infected Persons Attending a Southern HIV/AIDS Clinic. Southern Medical Journal 2006, 99: 472-481. PMID: 16711309, PMCID: PMC2761649, DOI: 10.1097/01.smj.0000215639.59563.83.Peer-Reviewed Original ResearchConceptsHIV medical careHIV diagnosisHIV/AIDS outpatient clinicMedical careHuman immunodeficiency virus (HIV) diagnosisHIV/AIDS clinicAIDS outpatient clinicMedicaid insurance coverageAIDS clinicMale sexOutpatient clinicDisease progressionDelayed initiationClinical careInfected personsPatientsCareInsurance coverageDiagnosisHIVVirus diagnosisClinicPresentationAIDSProgression
2004
Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy
Reid SE, Reid CA, Vermund SH. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. International Journal Of STD & AIDS 2004, 15: 713-716. PMID: 15537453, DOI: 10.1258/0956462042395195.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyInfected personsAntiretroviral treatment programAntiretroviral drug therapyHuman immunodeficiency virusResource-limited settingsAdherence strategiesImmunodeficiency virusSaharan AfricaAdequate adherenceDrug therapyDrug costsLeprosy controlTreatment programTherapyTuberculosisLeprosyAdherenceControl programs